In the News
McKesson Ventures highlights investment priorities amidst a trail of successful exits
In a recent interview, McKesson Ventures Partner Michelle Snyder discussed the latest trends in digital health and how McKesson Ventures chooses its investments. As a corporate venture group, the McKesson Ventures team is well positioned to identify emerging trends in digital health and invest in innovative business...
Women’s Digital Health Startups Reap Record VC Funding on Covid Surge
After being seen as an overly risky niche for years, women-focused digital health startups are finally beginning to see significant funding come their way. According to research and investment firm Rock Health, funding for women-focused digital health startups rose 105% last year to $418 million spread across 22...
Accolade to Announce Fiscal Fourth Quarter and Full Year 2021 Financial Results
Accolade, which provides personalized, technology-enabled solutions that help people better understand, navigate, and utilize the healthcare system and their workplace benefits, announced that it will release fiscal fourth quarter and full year 2021 financial results on Wednesday, May 5, 2021, after the market...
Health Data Analytics Startup Komodo Health’s $220M Series E propels it to $3.3B valuation
Komodo Health announced a $220 million Series E funding round led by Tiger Global Management and joined by Casdin Capital. Existing investors ICONIQ Growth, Andreesen Horowitz, and SVB Capital also participated in the round. The funding has propelled Komodo into the unicorn club with a valuation of $3.3 billion....
Evidation Raises $153 Million to Scale Virtual Health Capabilities of Achievement™ Platform
Evidation Health today announced the close of a $153 million Series E growth funding round to rapidly expand its virtual health programs on Achievement, the largest digital health network in the United States. The round was co-led by OMERS Growth Equity and Kaiser Permanente Group Trust; existing investors including...
CD&R, Merck, and McKesson Ventures Invest in Innovative Oncology Data and Informatics Platform
Oncology data and informatics platform M2GEN has announced a significant investment by three major venture investment firms: Clayton, Dubilier & Rice (CD&R), Merck Global Health Innovation Fund (Merck GHI), and McKesson Ventures. The investment will recapitalize M2GEN to accelerate the growth of M2GEN’s...
GRAIL, AccessHope Collaborate to Optimize Patient and Healthcare Provider Experience for Galleri, First-of-Kind Multi-Cancer Early Detection Blood Test
GRAIL has announced that it is joining forces with AccessHope™ to offer a world-class service experience to people who use Galleri™, GRAIL’s first-of-kind multi-cancer early detection blood test. This collaboration is part of GRAIL’s effort to help patients and their healthcare providers achieve favorable outcomes by...
The Apple Watch in clinical trials: Current uses and future possibilities
The use of wearables has been of great benefit to clinical trials: researchers can gather far more data, more often, more objectively, and more easily than ever before. And over the past year, digital tools for remote measurement made it possible to continue trials that otherwise would have been halted. Of all these...
GRAIL Announces First Health System to Offer Galleri, Novel Multi-Cancer Early Detection Blood Test
GRAIL today announced a partnership with the health system Providence to offer Galleri, GRAIL’s multi-cancer early detection blood test. Providence, based in Renton, Wash., will offer Galleri as a complement to recommended single cancer screening tests. Providence will initially deploy Galleri at its California,...
Grail Signs on Quest Diagnostics to Provide Phlebotomy for Cancer Detection Test
GRAIL has entered an agreement with Quest Diagnostics to provide phlebotomy services in support of its multi-cancer early detection blood test. The test, called Galleri, is expected to go to market in the second quarter after its PATHFINDER multi-site interventional study. Under the agreement, Quest’s phlebotomy...
Press Releases
Hims & Hers Expands Mental Health Offerings to Include Individual Online Therapy
McKesson Ventures portfolio company Hims & Hers recently announced that it has expanded its mental health offerings to include individual online therapy. Built to complement the platform’s existing services including access to online psychiatry and free,...
Empowerment Model: A New Partnership Model for Maximum Efficiency, Cost Savings, and Control, Upcoming Webinar Hosted by Xtalks
Two experts from Clinical Ink will present a webinar on the benefits of subscription models for clinical trials on July 13, 2021, at 11 a.m. ET. In the webinar, hosted by Xtalks, Clinical Ink Senior Director, Outcome Solutions Kim Romanello; and Manager, Product...
HumanFirst joins the FDA, HHS and more than 20 organizations and leading health companies to launch the Digital Health Measurement Collaborative Community (DATAcc)
More than 20 organizations and companies, including McKesson Ventures portfolio companies Aetion, Evidation Health, and Xealth, have joined together with other members of the Digital Medicine Society (DiMe) to create the Digital Health Measurement Collaborative...
PicnicHealth Partners with Komodo Health to Enrich Its Research Platform Utilizing Real-World Patient Data
Komodo Health and PicnicHealth have announced a partnership to support real-world evidence research programs for complex chronic illnesses like multiple sclerosis and hemophilia. With this partnership, PicnicHealth will enrich its database of de-identified patient...
Geisinger Health Plan Makes Searching for a Provider Easier With Kyruus-HealthSparq Integration
Geisinger Health Plan has expanded its partnership with HealthSparq, a healthcare guidance and transparency technology company serving health plans, and its parent company, Kyruus. GHP is the first health plan to use HealthSparq’s new Path to Care solution to power...